Bristol-Myers' win in patent case against Gilead raised to $1.2B
Share!
Business Insurance - Apr 10, 2020
A federal judge increased to $1.2 billion the damages that Gilead Sciences Inc. must pay to Bristol-Myers Squibb Co. in a patent infringement case regarding technology for treating cancer....
Recommended Articles